Rudolph, J., Roberts, G., & Luger, K. (2021). Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs. Nature Portfolio.
Cita Chicago Style (17a ed.)Rudolph, Johannes, Genevieve Roberts, y Karolin Luger. Histone Parylation Factor 1 Contributes to the Inhibition of PARP1 by Cancer Drugs. Nature Portfolio, 2021.
Cita MLA (8a ed.)Rudolph, Johannes, et al. Histone Parylation Factor 1 Contributes to the Inhibition of PARP1 by Cancer Drugs. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.